Pre-tax losses at Roche jump fourfold to €12.3m

RESTRUCTURING costs totalling €6.8 million led to pre-tax losses at the main Irish unit of pharma giant Roche increasing almost fourfold to €12.3m last year, new figures show.

According to returns just filed with the Companies Office, they show that the Swiss-owned Roche Ireland Ltd recorded the increase in losses after revenues dipped by 9.5% from €74.5m to €67.4m in the 12 months to the end of December last.

The figures show that the company’s performance was hit by a €6.8m restructuring charge as a result of making over 25 redundancies as part of a global restructuring.